What is GNMSF stock price today?

Visit our real-time dashboard for the current GNMSF stock price and live market data.

Is GNMSF stock going up or down today?

GNMSF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GNMSF stock now?

The decision to buy GNMSF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GNMSF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GNMSF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GNMSF stock overvalued or undervalued?

GNMSF currently trades at a P/E ratio of 18.39 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if GNMSF is fairly priced.

What is GNMSF's P/E ratio?

GNMSF has a price-to-earnings (P/E) ratio of 18.39, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is GNMSF's market cap?

GNMSF (Genmab A/S) has a market capitalization of $14.85 billion, making it a mid-cap stock.

What is GNMSF's price to book ratio?

Price-to-book ratio for GNMSF is available on our dashboard along with other valuation metrics.

Does GNMSF pay dividends?

GNMSF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is GNMSF's dividend yield?

GNMSF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is GNMSF stock a good long-term investment?

GNMSF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GNMSF's revenue growth rate?

Revenue growth data for GNMSF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for GNMSF are available on our dashboard with complete income statement analysis.

What are the risks of investing in GNMSF?

Key risks for GNMSF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GNMSF compare to its competitors?

Compare GNMSF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GNMSF's performance and positioning.

What is GNMSF's stock price target for 2026?

Visit our prediction page for AI-powered price targets for GNMSF with bull, base, and bear case scenarios.

What do analysts say about GNMSF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GNMSF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GNMSF's next earnings report?

GNMSF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GNMSF - Genmab A/S

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Genmab A/S

Genmab A/S (GNMSF) common stock

Price Chart

Loading chart...

GNMSF Key Statistics

Market Cap

$14.85B

P/E Ratio

18.39

How GNMSF Compares to Peers

GNMSF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GNMSF(This stock)	$14.85B	18.4	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 20, 2026 at 7:01 AM EDT

Ready to invest in GNMSF?

Commission-free trading available. Affiliate links.

Upcoming Events for GNMSF

Dashboard

Enter a ticker to analyze